Global Pregabalin API Market Insights, Forecast to 2029

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Pregabalin API Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Pregabalin API Market Size by Type, 2018 VS 2022 VS 2029
  • 1.2.2 Purity ≥99%
  • 1.2.3 Purity ≥99.5%
• 1.3 Market by Application
  • 1.3.1 Global Pregabalin API Market Size by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Tablet
  • 1.3.3 Capsule
  • 1.3.4 Oral Liquid
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Pregabalin API Production

• 2.1 Global Pregabalin API Production Capacity (2018-2029)
• 2.2 Global Pregabalin API Production by Region: 2018 VS 2022 VS 2029
• 2.3 Global Pregabalin API Production by Region
  • 2.3.1 Global Pregabalin API Historic Production by Region (2018-2023)
  • 2.3.2 Global Pregabalin API Forecasted Production by Region (2024-2029)
  • 2.3.3 Global Pregabalin API Production Market Share by Region (2018-2029)
• 2.4 North America
• 2.5 Europe
• 2.6 China
• 2.7 India
• 2.8 South Korea

3 Executive Summary

• 3.1 Global Pregabalin API Revenue Estimates and Forecasts 2018-2029
• 3.2 Global Pregabalin API Revenue by Region
  • 3.2.1 Global Pregabalin API Revenue by Region: 2018 VS 2022 VS 2029
  • 3.2.2 Global Pregabalin API Revenue by Region (2018-2023)
  • 3.2.3 Global Pregabalin API Revenue by Region (2024-2029)
  • 3.2.4 Global Pregabalin API Revenue Market Share by Region (2018-2029)
• 3.3 Global Pregabalin API Sales Estimates and Forecasts 2018-2029
• 3.4 Global Pregabalin API Sales by Region
  • 3.4.1 Global Pregabalin API Sales by Region: 2018 VS 2022 VS 2029
  • 3.4.2 Global Pregabalin API Sales by Region (2018-2023)
  • 3.4.3 Global Pregabalin API Sales by Region (2024-2029)
  • 3.4.4 Global Pregabalin API Sales Market Share by Region (2018-2029)
• 3.5 US & Canada
• 3.6 Europe
• 3.7 China
• 3.8 Asia (excluding China)
• 3.9 Middle East, Africa and Latin America

4 Competition by Manufactures

• 4.1 Global Pregabalin API Sales by Manufacturers
  • 4.1.1 Global Pregabalin API Sales by Manufacturers (2018-2023)
  • 4.1.2 Global Pregabalin API Sales Market Share by Manufacturers (2018-2023)
  • 4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pregabalin API in 2022
• 4.2 Global Pregabalin API Revenue by Manufacturers
  • 4.2.1 Global Pregabalin API Revenue by Manufacturers (2018-2023)
  • 4.2.2 Global Pregabalin API Revenue Market Share by Manufacturers (2018-2023)
  • 4.2.3 Global Top 10 and Top 5 Companies by Pregabalin API Revenue in 2022
• 4.3 Global Pregabalin API Sales Price by Manufacturers
• 4.4 Global Key Players of Pregabalin API, Industry Ranking, 2021 VS 2022 VS 2023
• 4.5 Analysis of Competitive Landscape
  • 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 4.5.2 Global Pregabalin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.6 Global Key Manufacturers of Pregabalin API, Manufacturing Base Distribution and Headquarters
• 4.7 Global Key Manufacturers of Pregabalin API, Product Offered and Application
• 4.8 Global Key Manufacturers of Pregabalin API, Date of Enter into This Industry
• 4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

• 5.1 Global Pregabalin API Sales by Type
  • 5.1.1 Global Pregabalin API Historical Sales by Type (2018-2023)
  • 5.1.2 Global Pregabalin API Forecasted Sales by Type (2024-2029)
  • 5.1.3 Global Pregabalin API Sales Market Share by Type (2018-2029)
• 5.2 Global Pregabalin API Revenue by Type
  • 5.2.1 Global Pregabalin API Historical Revenue by Type (2018-2023)
  • 5.2.2 Global Pregabalin API Forecasted Revenue by Type (2024-2029)
  • 5.2.3 Global Pregabalin API Revenue Market Share by Type (2018-2029)
• 5.3 Global Pregabalin API Price by Type
  • 5.3.1 Global Pregabalin API Price by Type (2018-2023)
  • 5.3.2 Global Pregabalin API Price Forecast by Type (2024-2029)

6 Market Size by Application

• 6.1 Global Pregabalin API Sales by Application
  • 6.1.1 Global Pregabalin API Historical Sales by Application (2018-2023)
  • 6.1.2 Global Pregabalin API Forecasted Sales by Application (2024-2029)
  • 6.1.3 Global Pregabalin API Sales Market Share by Application (2018-2029)
• 6.2 Global Pregabalin API Revenue by Application
  • 6.2.1 Global Pregabalin API Historical Revenue by Application (2018-2023)
  • 6.2.2 Global Pregabalin API Forecasted Revenue by Application (2024-2029)
  • 6.2.3 Global Pregabalin API Revenue Market Share by Application (2018-2029)
• 6.3 Global Pregabalin API Price by Application
  • 6.3.1 Global Pregabalin API Price by Application (2018-2023)
  • 6.3.2 Global Pregabalin API Price Forecast by Application (2024-2029)

7 US & Canada

• 7.1 US & Canada Pregabalin API Market Size by Type
  • 7.1.1 US & Canada Pregabalin API Sales by Type (2018-2029)
  • 7.1.2 US & Canada Pregabalin API Revenue by Type (2018-2029)
• 7.2 US & Canada Pregabalin API Market Size by Application
  • 7.2.1 US & Canada Pregabalin API Sales by Application (2018-2029)
  • 7.2.2 US & Canada Pregabalin API Revenue by Application (2018-2029)
• 7.3 US & Canada Pregabalin API Sales by Country
  • 7.3.1 US & Canada Pregabalin API Revenue by Country: 2018 VS 2022 VS 2029
  • 7.3.2 US & Canada Pregabalin API Sales by Country (2018-2029)
  • 7.3.3 US & Canada Pregabalin API Revenue by Country (2018-2029)
  • 7.3.4 U.S.
  • 7.3.5 Canada

8 Europe

• 8.1 Europe Pregabalin API Market Size by Type
  • 8.1.1 Europe Pregabalin API Sales by Type (2018-2029)
  • 8.1.2 Europe Pregabalin API Revenue by Type (2018-2029)
• 8.2 Europe Pregabalin API Market Size by Application
  • 8.2.1 Europe Pregabalin API Sales by Application (2018-2029)
  • 8.2.2 Europe Pregabalin API Revenue by Application (2018-2029)
• 8.3 Europe Pregabalin API Sales by Country
  • 8.3.1 Europe Pregabalin API Revenue by Country: 2018 VS 2022 VS 2029
  • 8.3.2 Europe Pregabalin API Sales by Country (2018-2029)
  • 8.3.3 Europe Pregabalin API Revenue by Country (2018-2029)
  • 8.3.4 Germany
  • 8.3.5 France
  • 8.3.6 U.K.
  • 8.3.7 Italy
  • 8.3.8 Russia

9 China

• 9.1 China Pregabalin API Market Size by Type
  • 9.1.1 China Pregabalin API Sales by Type (2018-2029)
  • 9.1.2 China Pregabalin API Revenue by Type (2018-2029)
• 9.2 China Pregabalin API Market Size by Application
  • 9.2.1 China Pregabalin API Sales by Application (2018-2029)
  • 9.2.2 China Pregabalin API Revenue by Application (2018-2029)

10 Asia (excluding China)

• 10.1 Asia Pregabalin API Market Size by Type
  • 10.1.1 Asia Pregabalin API Sales by Type (2018-2029)
  • 10.1.2 Asia Pregabalin API Revenue by Type (2018-2029)
• 10.2 Asia Pregabalin API Market Size by Application
  • 10.2.1 Asia Pregabalin API Sales by Application (2018-2029)
  • 10.2.2 Asia Pregabalin API Revenue by Application (2018-2029)
• 10.3 Asia Pregabalin API Sales by Region
  • 10.3.1 Asia Pregabalin API Revenue by Region: 2018 VS 2022 VS 2029
  • 10.3.2 Asia Pregabalin API Revenue by Region (2018-2029)
  • 10.3.3 Asia Pregabalin API Sales by Region (2018-2029)
  • 10.3.4 Japan
  • 10.3.5 South Korea
  • 10.3.6 China Taiwan
  • 10.3.7 Southeast Asia
  • 10.3.8 India

11 Middle East, Africa and Latin America

• 11.1 Middle East, Africa and Latin America Pregabalin API Market Size by Type
  • 11.1.1 Middle East, Africa and Latin America Pregabalin API Sales by Type (2018-2029)
  • 11.1.2 Middle East, Africa and Latin America Pregabalin API Revenue by Type (2018-2029)
• 11.2 Middle East, Africa and Latin America Pregabalin API Market Size by Application
  • 11.2.1 Middle East, Africa and Latin America Pregabalin API Sales by Application (2018-2029)
  • 11.2.2 Middle East, Africa and Latin America Pregabalin API Revenue by Application (2018-2029)
• 11.3 Middle East, Africa and Latin America Pregabalin API Sales by Country
  • 11.3.1 Middle East, Africa and Latin America Pregabalin API Revenue by Country: 2018 VS 2022 VS 2029
  • 11.3.2 Middle East, Africa and Latin America Pregabalin API Revenue by Country (2018-2029)
  • 11.3.3 Middle East, Africa and Latin America Pregabalin API Sales by Country (2018-2029)
  • 11.3.4 Brazil
  • 11.3.5 Mexico
  • 11.3.6 Turkey
  • 11.3.7 Israel
  • 11.3.8 GCC Countries

12 Corporate Profiles

• 12.1 SUANFARMA
  • 12.1.1 SUANFARMA Company Information
  • 12.1.2 SUANFARMA Overview
  • 12.1.3 SUANFARMA Pregabalin API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.1.4 SUANFARMA Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.1.5 SUANFARMA Recent Developments
• 12.2 VASUDHA PHARMA
  • 12.2.1 VASUDHA PHARMA Company Information
  • 12.2.2 VASUDHA PHARMA Overview
  • 12.2.3 VASUDHA PHARMA Pregabalin API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.2.4 VASUDHA PHARMA Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.2.5 VASUDHA PHARMA Recent Developments
• 12.3 Atom Pharma
  • 12.3.1 Atom Pharma Company Information
  • 12.3.2 Atom Pharma Overview
  • 12.3.3 Atom Pharma Pregabalin API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.3.4 Atom Pharma Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.3.5 Atom Pharma Recent Developments
• 12.4 Sienna Biotec
  • 12.4.1 Sienna Biotec Company Information
  • 12.4.2 Sienna Biotec Overview
  • 12.4.3 Sienna Biotec Pregabalin API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.4.4 Sienna Biotec Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.4.5 Sienna Biotec Recent Developments
• 12.5 Kopran
  • 12.5.1 Kopran Company Information
  • 12.5.2 Kopran Overview
  • 12.5.3 Kopran Pregabalin API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.5.4 Kopran Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.5.5 Kopran Recent Developments
• 12.6 Teva
  • 12.6.1 Teva Company Information
  • 12.6.2 Teva Overview
  • 12.6.3 Teva Pregabalin API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.6.4 Teva Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.6.5 Teva Recent Developments
• 12.7 Afton Pharma
  • 12.7.1 Afton Pharma Company Information
  • 12.7.2 Afton Pharma Overview
  • 12.7.3 Afton Pharma Pregabalin API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.7.4 Afton Pharma Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.7.5 Afton Pharma Recent Developments
• 12.8 Cadila
  • 12.8.1 Cadila Company Information
  • 12.8.2 Cadila Overview
  • 12.8.3 Cadila Pregabalin API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.8.4 Cadila Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.8.5 Cadila Recent Developments
• 12.9 Sunshine Pharmaceutical
  • 12.9.1 Sunshine Pharmaceutical Company Information
  • 12.9.2 Sunshine Pharmaceutical Overview
  • 12.9.3 Sunshine Pharmaceutical Pregabalin API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.9.4 Sunshine Pharmaceutical Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.9.5 Sunshine Pharmaceutical Recent Developments
• 12.10 Hanmi Fine Chemical
  • 12.10.1 Hanmi Fine Chemical Company Information
  • 12.10.2 Hanmi Fine Chemical Overview
  • 12.10.3 Hanmi Fine Chemical Pregabalin API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.10.4 Hanmi Fine Chemical Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.10.5 Hanmi Fine Chemical Recent Developments
• 12.11 Rivocean Jiangsu Pharmaceutical
  • 12.11.1 Rivocean Jiangsu Pharmaceutical Company Information
  • 12.11.2 Rivocean Jiangsu Pharmaceutical Overview
  • 12.11.3 Rivocean Jiangsu Pharmaceutical Pregabalin API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.11.4 Rivocean Jiangsu Pharmaceutical Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.11.5 Rivocean Jiangsu Pharmaceutical Recent Developments
• 12.12 Hubei Vanz Pharm
  • 12.12.1 Hubei Vanz Pharm Company Information
  • 12.12.2 Hubei Vanz Pharm Overview
  • 12.12.3 Hubei Vanz Pharm Pregabalin API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.12.4 Hubei Vanz Pharm Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.12.5 Hubei Vanz Pharm Recent Developments
• 12.13 Menovo
  • 12.13.1 Menovo Company Information
  • 12.13.2 Menovo Overview
  • 12.13.3 Menovo Pregabalin API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.13.4 Menovo Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.13.5 Menovo Recent Developments
• 12.14 Saintsun
  • 12.14.1 Saintsun Company Information
  • 12.14.2 Saintsun Overview
  • 12.14.3 Saintsun Pregabalin API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.14.4 Saintsun Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.14.5 Saintsun Recent Developments
• 12.15 SyncoZymes
  • 12.15.1 SyncoZymes Company Information
  • 12.15.2 SyncoZymes Overview
  • 12.15.3 SyncoZymes Pregabalin API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.15.4 SyncoZymes Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.15.5 SyncoZymes Recent Developments
• 12.16 Taian Aidi Biotechnology
  • 12.16.1 Taian Aidi Biotechnology Company Information
  • 12.16.2 Taian Aidi Biotechnology Overview
  • 12.16.3 Taian Aidi Biotechnology Pregabalin API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.16.4 Taian Aidi Biotechnology Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.16.5 Taian Aidi Biotechnology Recent Developments

13 Industry Chain and Sales Channels Analysis

• 13.1 Pregabalin API Industry Chain Analysis
• 13.2 Pregabalin API Key Raw Materials
  • 13.2.1 Key Raw Materials
  • 13.2.2 Raw Materials Key Suppliers
• 13.3 Pregabalin API Production Mode & Process
• 13.4 Pregabalin API Sales and Marketing
  • 13.4.1 Pregabalin API Sales Channels
  • 13.4.2 Pregabalin API Distributors
• 13.5 Pregabalin API Customers

14 Pregabalin API Market Dynamics

• 14.1 Pregabalin API Industry Trends
• 14.2 Pregabalin API Market Drivers
• 14.3 Pregabalin API Market Challenges
• 14.4 Pregabalin API Market Restraints

15 Key Finding in The Global Pregabalin API Study

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details
• 16.3 Disclaimer

List of Tables

• Table 1. Global Pregabalin API Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Table 2. Major Manufacturers of Purity ≥99%
• Table 3. Major Manufacturers of Purity ≥99.5%
• Table 4. Global Pregabalin API Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Table 5. Global Pregabalin API Production by Region: 2018 VS 2022 VS 2029 (Tons)
• Table 6. Global Pregabalin API Production by Region (2018-2023) & (Tons)
• Table 7. Global Pregabalin API Production by Region (2024-2029) & (Tons)
• Table 8. Global Pregabalin API Production Market Share by Region (2018-2023)
• Table 9. Global Pregabalin API Production Market Share by Region (2024-2029)
• Table 10. Global Pregabalin API Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 11. Global Pregabalin API Revenue by Region (2018-2023) & (US$ Million)
• Table 12. Global Pregabalin API Revenue by Region (2024-2029) & (US$ Million)
• Table 13. Global Pregabalin API Revenue Market Share by Region (2018-2023)
• Table 14. Global Pregabalin API Revenue Market Share by Region (2024-2029)
• Table 15. Global Pregabalin API Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 16. Global Pregabalin API Sales by Region (2018-2023) & (Tons)
• Table 17. Global Pregabalin API Sales by Region (2024-2029) & (Tons)
• Table 18. Global Pregabalin API Sales Market Share by Region (2018-2023)
• Table 19. Global Pregabalin API Sales Market Share by Region (2024-2029)
• Table 20. Global Pregabalin API Sales by Manufacturers (2018-2023) & (Tons)
• Table 21. Global Pregabalin API Sales Share by Manufacturers (2018-2023)
• Table 22. Global Pregabalin API Revenue by Manufacturers (2018-2023) & (US$ Million)
• Table 23. Global Pregabalin API Revenue Share by Manufacturers (2018-2023)
• Table 24. Pregabalin API Price by Manufacturers 2018-2023 (US$/Ton)
• Table 25. Global Key Players of Pregabalin API, Industry Ranking, 2021 VS 2022 VS 2023
• Table 26. Global Pregabalin API Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 27. Global Pregabalin API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pregabalin API as of 2022)
• Table 28. Global Key Manufacturers of Pregabalin API, Manufacturing Base Distribution and Headquarters
• Table 29. Global Key Manufacturers of Pregabalin API, Product Offered and Application
• Table 30. Global Key Manufacturers of Pregabalin API, Date of Enter into This Industry
• Table 31. Mergers & Acquisitions, Expansion Plans
• Table 32. Global Pregabalin API Sales by Type (2018-2023) & (Tons)
• Table 33. Global Pregabalin API Sales by Type (2024-2029) & (Tons)
• Table 34. Global Pregabalin API Sales Share by Type (2018-2023)
• Table 35. Global Pregabalin API Sales Share by Type (2024-2029)
• Table 36. Global Pregabalin API Revenue by Type (2018-2023) & (US$ Million)
• Table 37. Global Pregabalin API Revenue by Type (2024-2029) & (US$ Million)
• Table 38. Global Pregabalin API Revenue Share by Type (2018-2023)
• Table 39. Global Pregabalin API Revenue Share by Type (2024-2029)
• Table 40. Pregabalin API Price by Type (2018-2023) & (US$/Ton)
• Table 41. Global Pregabalin API Price Forecast by Type (2024-2029) & (US$/Ton)
• Table 42. Global Pregabalin API Sales by Application (2018-2023) & (Tons)
• Table 43. Global Pregabalin API Sales by Application (2024-2029) & (Tons)
• Table 44. Global Pregabalin API Sales Share by Application (2018-2023)
• Table 45. Global Pregabalin API Sales Share by Application (2024-2029)
• Table 46. Global Pregabalin API Revenue by Application (2018-2023) & (US$ Million)
• Table 47. Global Pregabalin API Revenue by Application (2024-2029) & (US$ Million)
• Table 48. Global Pregabalin API Revenue Share by Application (2018-2023)
• Table 49. Global Pregabalin API Revenue Share by Application (2024-2029)
• Table 50. Pregabalin API Price by Application (2018-2023) & (US$/Ton)
• Table 51. Global Pregabalin API Price Forecast by Application (2024-2029) & (US$/Ton)
• Table 52. US & Canada Pregabalin API Sales by Type (2018-2023) & (Tons)
• Table 53. US & Canada Pregabalin API Sales by Type (2024-2029) & (Tons)
• Table 54. US & Canada Pregabalin API Revenue by Type (2018-2023) & (US$ Million)
• Table 55. US & Canada Pregabalin API Revenue by Type (2024-2029) & (US$ Million)
• Table 56. US & Canada Pregabalin API Sales by Application (2018-2023) & (Tons)
• Table 57. US & Canada Pregabalin API Sales by Application (2024-2029) & (Tons)
• Table 58. US & Canada Pregabalin API Revenue by Application (2018-2023) & (US$ Million)
• Table 59. US & Canada Pregabalin API Revenue by Application (2024-2029) & (US$ Million)
• Table 60. US & Canada Pregabalin API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 61. US & Canada Pregabalin API Revenue by Country (2018-2023) & (US$ Million)
• Table 62. US & Canada Pregabalin API Revenue by Country (2024-2029) & (US$ Million)
• Table 63. US & Canada Pregabalin API Sales by Country (2018-2023) & (Tons)
• Table 64. US & Canada Pregabalin API Sales by Country (2024-2029) & (Tons)
• Table 65. Europe Pregabalin API Sales by Type (2018-2023) & (Tons)
• Table 66. Europe Pregabalin API Sales by Type (2024-2029) & (Tons)
• Table 67. Europe Pregabalin API Revenue by Type (2018-2023) & (US$ Million)
• Table 68. Europe Pregabalin API Revenue by Type (2024-2029) & (US$ Million)
• Table 69. Europe Pregabalin API Sales by Application (2018-2023) & (Tons)
• Table 70. Europe Pregabalin API Sales by Application (2024-2029) & (Tons)
• Table 71. Europe Pregabalin API Revenue by Application (2018-2023) & (US$ Million)
• Table 72. Europe Pregabalin API Revenue by Application (2024-2029) & (US$ Million)
• Table 73. Europe Pregabalin API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 74. Europe Pregabalin API Revenue by Country (2018-2023) & (US$ Million)
• Table 75. Europe Pregabalin API Revenue by Country (2024-2029) & (US$ Million)
• Table 76. Europe Pregabalin API Sales by Country (2018-2023) & (Tons)
• Table 77. Europe Pregabalin API Sales by Country (2024-2029) & (Tons)
• Table 78. China Pregabalin API Sales by Type (2018-2023) & (Tons)
• Table 79. China Pregabalin API Sales by Type (2024-2029) & (Tons)
• Table 80. China Pregabalin API Revenue by Type (2018-2023) & (US$ Million)
• Table 81. China Pregabalin API Revenue by Type (2024-2029) & (US$ Million)
• Table 82. China Pregabalin API Sales by Application (2018-2023) & (Tons)
• Table 83. China Pregabalin API Sales by Application (2024-2029) & (Tons)
• Table 84. China Pregabalin API Revenue by Application (2018-2023) & (US$ Million)
• Table 85. China Pregabalin API Revenue by Application (2024-2029) & (US$ Million)
• Table 86. Asia Pregabalin API Sales by Type (2018-2023) & (Tons)
• Table 87. Asia Pregabalin API Sales by Type (2024-2029) & (Tons)
• Table 88. Asia Pregabalin API Revenue by Type (2018-2023) & (US$ Million)
• Table 89. Asia Pregabalin API Revenue by Type (2024-2029) & (US$ Million)
• Table 90. Asia Pregabalin API Sales by Application (2018-2023) & (Tons)
• Table 91. Asia Pregabalin API Sales by Application (2024-2029) & (Tons)
• Table 92. Asia Pregabalin API Revenue by Application (2018-2023) & (US$ Million)
• Table 93. Asia Pregabalin API Revenue by Application (2024-2029) & (US$ Million)
• Table 94. Asia Pregabalin API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 95. Asia Pregabalin API Revenue by Region (2018-2023) & (US$ Million)
• Table 96. Asia Pregabalin API Revenue by Region (2024-2029) & (US$ Million)
• Table 97. Asia Pregabalin API Sales by Region (2018-2023) & (Tons)
• Table 98. Asia Pregabalin API Sales by Region (2024-2029) & (Tons)
• Table 99. Middle East, Africa and Latin America Pregabalin API Sales by Type (2018-2023) & (Tons)
• Table 100. Middle East, Africa and Latin America Pregabalin API Sales by Type (2024-2029) & (Tons)
• Table 101. Middle East, Africa and Latin America Pregabalin API Revenue by Type (2018-2023) & (US$ Million)
• Table 102. Middle East, Africa and Latin America Pregabalin API Revenue by Type (2024-2029) & (US$ Million)
• Table 103. Middle East, Africa and Latin America Pregabalin API Sales by Application (2018-2023) & (Tons)
• Table 104. Middle East, Africa and Latin America Pregabalin API Sales by Application (2024-2029) & (Tons)
• Table 105. Middle East, Africa and Latin America Pregabalin API Revenue by Application (2018-2023) & (US$ Million)
• Table 106. Middle East, Africa and Latin America Pregabalin API Revenue by Application (2024-2029) & (US$ Million)
• Table 107. Middle East, Africa and Latin America Pregabalin API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 108. Middle East, Africa and Latin America Pregabalin API Revenue by Country (2018-2023) & (US$ Million)
• Table 109. Middle East, Africa and Latin America Pregabalin API Revenue by Country (2024-2029) & (US$ Million)
• Table 110. Middle East, Africa and Latin America Pregabalin API Sales by Country (2018-2023) & (Tons)
• Table 111. Middle East, Africa and Latin America Pregabalin API Sales by Country (2024-2029) & (Tons)
• Table 112. SUANFARMA Company Information
• Table 113. SUANFARMA Description and Major Businesses
• Table 114. SUANFARMA Pregabalin API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 115. SUANFARMA Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
• Table 116. SUANFARMA Recent Development
• Table 117. VASUDHA PHARMA Company Information
• Table 118. VASUDHA PHARMA Description and Major Businesses
• Table 119. VASUDHA PHARMA Pregabalin API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 120. VASUDHA PHARMA Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
• Table 121. VASUDHA PHARMA Recent Development
• Table 122. Atom Pharma Company Information
• Table 123. Atom Pharma Description and Major Businesses
• Table 124. Atom Pharma Pregabalin API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 125. Atom Pharma Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
• Table 126. Atom Pharma Recent Development
• Table 127. Sienna Biotec Company Information
• Table 128. Sienna Biotec Description and Major Businesses
• Table 129. Sienna Biotec Pregabalin API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 130. Sienna Biotec Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
• Table 131. Sienna Biotec Recent Development
• Table 132. Kopran Company Information
• Table 133. Kopran Description and Major Businesses
• Table 134. Kopran Pregabalin API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 135. Kopran Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
• Table 136. Kopran Recent Development
• Table 137. Teva Company Information
• Table 138. Teva Description and Major Businesses
• Table 139. Teva Pregabalin API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 140. Teva Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
• Table 141. Teva Recent Development
• Table 142. Afton Pharma Company Information
• Table 143. Afton Pharma Description and Major Businesses
• Table 144. Afton Pharma Pregabalin API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 145. Afton Pharma Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
• Table 146. Afton Pharma Recent Development
• Table 147. Cadila Company Information
• Table 148. Cadila Description and Major Businesses
• Table 149. Cadila Pregabalin API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 150. Cadila Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
• Table 151. Cadila Recent Development
• Table 152. Sunshine Pharmaceutical Company Information
• Table 153. Sunshine Pharmaceutical Description and Major Businesses
• Table 154. Sunshine Pharmaceutical Pregabalin API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 155. Sunshine Pharmaceutical Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
• Table 156. Sunshine Pharmaceutical Recent Development
• Table 157. Hanmi Fine Chemical Company Information
• Table 158. Hanmi Fine Chemical Description and Major Businesses
• Table 159. Hanmi Fine Chemical Pregabalin API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 160. Hanmi Fine Chemical Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
• Table 161. Hanmi Fine Chemical Recent Development
• Table 162. Rivocean Jiangsu Pharmaceutical Company Information
• Table 163. Rivocean Jiangsu Pharmaceutical Description and Major Businesses
• Table 164. Rivocean Jiangsu Pharmaceutical Pregabalin API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 165. Rivocean Jiangsu Pharmaceutical Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
• Table 166. Rivocean Jiangsu Pharmaceutical Recent Development
• Table 167. Hubei Vanz Pharm Company Information
• Table 168. Hubei Vanz Pharm Description and Major Businesses
• Table 169. Hubei Vanz Pharm Pregabalin API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 170. Hubei Vanz Pharm Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
• Table 171. Hubei Vanz Pharm Recent Development
• Table 172. Menovo Company Information
• Table 173. Menovo Description and Major Businesses
• Table 174. Menovo Pregabalin API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 175. Menovo Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
• Table 176. Menovo Recent Development
• Table 177. Saintsun Company Information
• Table 178. Saintsun Description and Major Businesses
• Table 179. Saintsun Pregabalin API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 180. Saintsun Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
• Table 181. Saintsun Recent Development
• Table 182. SyncoZymes Company Information
• Table 183. SyncoZymes Description and Major Businesses
• Table 184. SyncoZymes Pregabalin API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 185. SyncoZymes Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
• Table 186. SyncoZymes Recent Development
• Table 187. Taian Aidi Biotechnology Company Information
• Table 188. Taian Aidi Biotechnology Description and Major Businesses
• Table 189. Taian Aidi Biotechnology Pregabalin API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 190. Taian Aidi Biotechnology Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
• Table 191. Taian Aidi Biotechnology Recent Development
• Table 192. Key Raw Materials Lists
• Table 193. Raw Materials Key Suppliers Lists
• Table 194. Pregabalin API Distributors List
• Table 195. Pregabalin API Customers List
• Table 196. Pregabalin API Market Trends
• Table 197. Pregabalin API Market Drivers
• Table 198. Pregabalin API Market Challenges
• Table 199. Pregabalin API Market Restraints
• Table 200. Research Programs/Design for This Report
• Table 201. Key Data Information from Secondary Sources
• Table 202. Key Data Information from Primary Sources

List of Figures

• Figure 1. Pregabalin API Product Picture
• Figure 2. Global Pregabalin API Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 3. Global Pregabalin API Market Share by Type in 2022 & 2029
• Figure 4. Purity ≥99% Product Picture
• Figure 5. Purity ≥99.5% Product Picture
• Figure 6. Global Pregabalin API Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 7. Global Pregabalin API Market Share by Application in 2022 & 2029
• Figure 8. Tablet
• Figure 9. Capsule
• Figure 10. Oral Liquid
• Figure 11. Pregabalin API Report Years Considered
• Figure 12. Global Pregabalin API Capacity, Production and Utilization (2018-2029) & (Tons)
• Figure 13. Global Pregabalin API Production Market Share by Region in Percentage: 2022 Versus 2029
• Figure 14. Global Pregabalin API Production Market Share by Region (2018-2029)
• Figure 15. Pregabalin API Production Growth Rate in North America (2018-2029) & (Tons)
• Figure 16. Pregabalin API Production Growth Rate in Europe (2018-2029) & (Tons)
• Figure 17. Pregabalin API Production Growth Rate in China (2018-2029) & (Tons)
• Figure 18. Pregabalin API Production Growth Rate in India (2018-2029) & (Tons)
• Figure 19. Pregabalin API Production Growth Rate in South Korea (2018-2029) & (Tons)
• Figure 20. Global Pregabalin API Revenue, (US$ Million), 2018 VS 2022 VS 2029
• Figure 21. Global Pregabalin API Revenue 2018-2029 (US$ Million)
• Figure 22. Global Pregabalin API Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Figure 23. Global Pregabalin API Revenue Market Share by Region in Percentage: 2022 Versus 2029
• Figure 24. Global Pregabalin API Revenue Market Share by Region (2018-2029)
• Figure 25. Global Pregabalin API Sales 2018-2029 ((Tons)
• Figure 26. Global Pregabalin API Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (Tons)
• Figure 27. Global Pregabalin API Sales Market Share by Region (2018-2029)
• Figure 28. US & Canada Pregabalin API Sales YoY (2018-2029) & (Tons)
• Figure 29. US & Canada Pregabalin API Revenue YoY (2018-2029) & (US$ Million)
• Figure 30. Europe Pregabalin API Sales YoY (2018-2029) & (Tons)
• Figure 31. Europe Pregabalin API Revenue YoY (2018-2029) & (US$ Million)
• Figure 32. China Pregabalin API Sales YoY (2018-2029) & (Tons)
• Figure 33. China Pregabalin API Revenue YoY (2018-2029) & (US$ Million)
• Figure 34. Asia (excluding China) Pregabalin API Sales YoY (2018-2029) & (Tons)
• Figure 35. Asia (excluding China) Pregabalin API Revenue YoY (2018-2029) & (US$ Million)
• Figure 36. Middle East, Africa and Latin America Pregabalin API Sales YoY (2018-2029) & (Tons)
• Figure 37. Middle East, Africa and Latin America Pregabalin API Revenue YoY (2018-2029) & (US$ Million)
• Figure 38. The Pregabalin API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
• Figure 39. The Top 5 and 10 Largest Manufacturers of Pregabalin API in the World: Market Share by Pregabalin API Revenue in 2022
• Figure 40. Global Pregabalin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
• Figure 41. Global Pregabalin API Sales Market Share by Type (2018-2029)
• Figure 42. Global Pregabalin API Revenue Market Share by Type (2018-2029)
• Figure 43. Global Pregabalin API Sales Market Share by Application (2018-2029)
• Figure 44. Global Pregabalin API Revenue Market Share by Application (2018-2029)
• Figure 45. US & Canada Pregabalin API Sales Market Share by Type (2018-2029)
• Figure 46. US & Canada Pregabalin API Revenue Market Share by Type (2018-2029)
• Figure 47. US & Canada Pregabalin API Sales Market Share by Application (2018-2029)
• Figure 48. US & Canada Pregabalin API Revenue Market Share by Application (2018-2029)
• Figure 49. US & Canada Pregabalin API Revenue Share by Country (2018-2029)
• Figure 50. US & Canada Pregabalin API Sales Share by Country (2018-2029)
• Figure 51. U.S. Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 52. Canada Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 53. Europe Pregabalin API Sales Market Share by Type (2018-2029)
• Figure 54. Europe Pregabalin API Revenue Market Share by Type (2018-2029)
• Figure 55. Europe Pregabalin API Sales Market Share by Application (2018-2029)
• Figure 56. Europe Pregabalin API Revenue Market Share by Application (2018-2029)
• Figure 57. Europe Pregabalin API Revenue Share by Country (2018-2029)
• Figure 58. Europe Pregabalin API Sales Share by Country (2018-2029)
• Figure 59. Germany Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 60. France Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 61. U.K. Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 62. Italy Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 63. Russia Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 64. China Pregabalin API Sales Market Share by Type (2018-2029)
• Figure 65. China Pregabalin API Revenue Market Share by Type (2018-2029)
• Figure 66. China Pregabalin API Sales Market Share by Application (2018-2029)
• Figure 67. China Pregabalin API Revenue Market Share by Application (2018-2029)
• Figure 68. Asia Pregabalin API Sales Market Share by Type (2018-2029)
• Figure 69. Asia Pregabalin API Revenue Market Share by Type (2018-2029)
• Figure 70. Asia Pregabalin API Sales Market Share by Application (2018-2029)
• Figure 71. Asia Pregabalin API Revenue Market Share by Application (2018-2029)
• Figure 72. Asia Pregabalin API Revenue Share by Region (2018-2029)
• Figure 73. Asia Pregabalin API Sales Share by Region (2018-2029)
• Figure 74. Japan Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 75. South Korea Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 76. China Taiwan Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 77. Southeast Asia Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 78. India Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 79. Middle East, Africa and Latin America Pregabalin API Sales Market Share by Type (2018-2029)
• Figure 80. Middle East, Africa and Latin America Pregabalin API Revenue Market Share by Type (2018-2029)
• Figure 81. Middle East, Africa and Latin America Pregabalin API Sales Market Share by Application (2018-2029)
• Figure 82. Middle East, Africa and Latin America Pregabalin API Revenue Market Share by Application (2018-2029)
• Figure 83. Middle East, Africa and Latin America Pregabalin API Revenue Share by Country (2018-2029)
• Figure 84. Middle East, Africa and Latin America Pregabalin API Sales Share by Country (2018-2029)
• Figure 85. Brazil Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 86. Mexico Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 87. Turkey Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 88. Israel Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 89. GCC Countries Pregabalin API Revenue (2018-2029) & (US$ Million)
• Figure 90. Pregabalin API Value Chain
• Figure 91. Pregabalin API Production Process
• Figure 92. Channels of Distribution
• Figure 93. Distributors Profiles
• Figure 94. Bottom-up and Top-down Approaches for This Report
• Figure 95. Data Triangulation
• Figure 96. Key Executives Interviewed